GANGLIONATED PLEXI ABLATION FOR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION  by Pokushalov, Evgeny et al.
E25
JACC April 5, 2011
Volume 57, Issue 14
   CARDIAC ARRHYTHMIAS 
GANGLIONATED PLEXI ABLATION FOR LONGSTANDING PERSISTENT ATRIAL FIBRILLATION
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Sunday, April 03, 2011, 10:00 a.m.-11:15 a.m.
Session Title: Clinical Electrophysiology -- Catheter Ablation for AF
Abstract Category: 26. Clinical Electrophysiology—Supraventricular Arrhythmias
Session-Poster Board Number: 1020-416
Authors: Evgeny Pokushalov, Aleksandr Romanov, Sergey Artemenko, Vitaliy Shabanov, Ilya Stenin, Aleksandr Karaskov, Demosthenes Katritsis, State 
Research Institute of Circulation Pathology, Novosibirsk, Russian Federation
Background:  The potential efficacy of ganglionated plexi (GP) ablation in the setting of longstanding persistent atrial fibrillation (AF) is not known. 
Methods:  Anatomic ablation at the areas of GP in the left atrium was performed in 89 patients with symptomatic, drug-refractory, persistent AF 
(71 men, 56±7 years of age). In 29 patients a second procedure by means of circumferential pulmonary vein (PV) isolation was performed, and 5 of 
them were subjected to a third circumferential ablation.
Results:  At 16±7 months after the final ablation procedure, 53 (59.6%) of the 89 patients were in sinus rhythm in the absence of antiarrhythmic 
drug therapy, 5 (5.6%) patients had permanent AF, and 31 (34.8%) patients had paroxysmal AF. The long-term success rate for patients who 
underwent a single ablation procedure with only GP ablation was 38.2% over a follow-up of 24±3 months. Independent predictors of later arrhythmia 
recurrences were left atrial diameter [HR 1.039 (1.00-1.07), P = 0.028] and duration of AF prior to ablation [HR 1.116 (1.02-1.22), P = 0.008].
Conclusions:  GP ablation in chronic AF results in long-term maintenance of sinus rhythm in 38.2% of cases. Repeat 
procedures with circumferential isolation of all PV offer a success rate of 59.6% over a follow-up of 16±7 months. 
